UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Screening for Glucose Perturbations and Risk Factor Management in Dysglycemic Patients With Coronary Artery Disease-A Persistent Challenge in Need of Substantial Improvement: A Report From ESC EORP EUROASPIRE V

Diabetes care, 2020-04, Vol.43 (4), p.726-733

2020

Volltextzugriff (PDF)

Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2

Diabetologia, 2018-10, Vol.61 (10), p.2087-2097

2018

Volltextzugriff (PDF)

The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia

Diabetes, obesity & metabolism, 2012-01, Vol.14 (1), p.5-14

2012

Volltextzugriff (PDF)

Development of SGLT1 and SGLT2 inhibitors

Diabetologia, 2018-10, Vol.61 (10), p.2079-2086

2018

Volltextzugriff (PDF)

Editorial on “Quantification of Cerebral Glucose Concentrations via Detection of the H1‐α‐Glucose Peak in 1H MRS at 7T”

Journal of magnetic resonance imaging, 2024-02, Vol.59 (2), p.673-674

2024

Volltextzugriff (PDF)

‘Smart’ insulin-delivery technologies and intrinsic glucose-responsive insulin analogues

Diabetologia, 2021-05, Vol.64 (5), p.1016-1029

2021

Volltextzugriff (PDF)

The protein family of glucose transport facilitators: It's not only about glucose after all

IUBMB life, 2010-05, Vol.62 (5), p.315-333

Augustin, Robert

2010

Volltextzugriff (PDF)

What does sodium‐glucose co‐transporter 1 inhibition add: Prospects for dual inhibition

Diabetes, obesity & metabolism, 2019-04, Vol.21 (S2), p.43-52

2019

Volltextzugriff (PDF)

Loss of function of renal Glut2 reverses hyperglycaemia and normalises body weight in mouse models of diabetes and obesity

Diabetologia, 2022-06, Vol.65 (6), p.1032-1047

2022

Volltextzugriff (PDF)

Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal Gestational Diabetes Mellitus and Childhood Glucose Metabolism

Diabetes care, 2019-03, Vol.42 (3), p.372-380

2019

Volltextzugriff (PDF)

In Vitro and In Vivo Inhibition of Intestinal Glucose Transport by Guava (Psidium Guajava) Extracts

Molecular nutrition & food research, 2018-06, Vol.62 (11), p.e1701012-n/a

2018

Volltextzugriff (PDF)

Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance : Results from the veterans administration genetic epidemiology study

Diabetes (New York, N.Y.), 2006-05, Vol.55 (5), p.1430-1435

2006

Volltextzugriff (PDF)

Structural basis of inhibition of the human SGLT2–MAP17 glucose transporter

Nature (London), 2022-01, Vol.601 (7892), p.280-284

2022

Volltextzugriff (PDF)

Do sodium‐glucose co‐transporter‐2 inhibitors increase plasma glucagon by direct actions on the alpha cell? And does the increase matter for the associated increase in endogenous glucose production?

Diabetes, obesity & metabolism, 2021-09, Vol.23 (9), p.2009-2019

2021

Volltextzugriff (PDF)

Canagliflozin Lowers Postprandial Glucose and Insulin by Delaying Intestinal Glucose Absorption in Addition to Increasing Urinary Glucose Excretion: Results of a randomized, placebo-controlled study

Diabetes care, 2013-08, Vol.36 (8), p.2154-2161

2013

Volltextzugriff (PDF)

Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart

Heart (British Cardiac Society), 2007-01, Vol.93 (1), p.72-77

2007

Volltextzugriff (PDF)

No direct effect of SGLT2 activity on glucagon secretion

Diabetologia, 2019-06, Vol.62 (6), p.1011-1023

2019

Volltextzugriff (PDF)

Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring

Diabetes care, 2018-11, Vol.41 (11), p.2275-2280

2018

Volltextzugriff (PDF)

Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection

Science (American Association for the Advancement of Science), 2018-03, Vol.359 (6382), p.1376-1383

2018

Volltextzugriff (PDF)

Dapagliflozin, a Selective SGLT2 Inhibitor, Improves Glucose Homeostasis in Normal and Diabetic Rats

Diabetes (New York, N.Y.), 2008-06, Vol.57 (6), p.1723-1729

2008

Volltextzugriff (PDF)

Reduction in Global Myocardial Glucose Metabolism in Subjects With 1-Hour Postload Hyperglycemia and Impaired Glucose Tolerance

Diabetes care, 2020-03, Vol.43 (3), p.669-676

2020

Volltextzugriff (PDF)

Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal Glycemia and Childhood Glucose Metabolism

Diabetes care, 2019-03, Vol.42 (3), p.381-392

2019

Volltextzugriff (PDF)

Dapagliflozin improves insulin resistance and glucose intolerance in a novel transgenic rat model of chronic glucose overproduction and glucose toxicity

Diabetes, obesity & metabolism, 2017-08, Vol.19 (8), p.1135-1146

2017

Volltextzugriff (PDF)

Understanding the clinical implications of differences between glucose management indicator and glycated haemoglobin

Diabetes, obesity & metabolism, 2022-04, Vol.24 (4), p.599-608

2022

Volltextzugriff (PDF)

Sodium–glucose cotransporters: Functional properties and pharmaceutical potential

Journal of diabetes investigation, 2020-07, Vol.11 (4), p.770-782

2020

Volltextzugriff (PDF)

1 – 25 von 172.674

Suche als RSS-Feed

Aktive Filter

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

KollektionOxford Journals Current Collection

KollektionJournals@Ovid Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(164.272)
Mit Volltextzugriff
(137.103)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

7 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(135.304)
Life Sciences & Biomedicine
(132.077)
Humans
(97.972)
Male
(71.153)
Biological And Medical Sciences
(62.630)
Female
(62.112)
Glucose
(57.954)
Medical Sciences
(53.117)
Diabetes
(50.312)
Endocrinology & Metabolism
(45.781)
Animals
(45.288)
Adult
(38.847)
Endocrinopathies
(38.175)
Endocrine Pancreas. Apud Cells
(37.446)
Middle Aged
(37.134)
Diabetes. Impaired Glucose Tolerance
(37.005)
Insulin
(27.391)
Blood Glucose - Metabolism
(27.332)
Diabetes Mellitus
(25.515)
Etiopathogenesis. Screening. Investigations. Target Tissue Resistance
(23.965)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Ovid SocietyJournals and Single Titles
(172.674)
MEDLINE
(140.735)
EZB Electronic Journals Library
(83.662)
Ingenta.com
(54.565)
Wiley-Blackwell Journals
(47.501)
Publisher or Other Site
(45.528)
Wiley Online Library Full Collection 2018
(37.559)
Springer Nature - Complete Springer Journals
(33.098)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(31.384)
IngentaConnect Journals
(28.101)
SAGE Journals Online
(6.634)
BMJ
(5.902)
Nature_系列刊
(5.550)
Access via ScienceDirect (Elsevier)
(4.403)
JSTOR
(4.379)
Nexis Uni
(3.692)
BMJ Journals Archiv - DFG Nationallizenzen
(3.161)
EBSCO_Psychology & Behavioral Sciences Collection
(3.124)
Taylor & Francis Journals
(3.099)
Cambridge Journals Online (DEFF)
(2.883)
Oxford Journals
(0)

16 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Diabetes
(17.039)
Diabetes Care
(12.226)
Diabetologia
(9.441)
Diabetic Medicine
(5.901)
Diabetes, Obesity & Metabolism
(2.657)
The Journal Of Clinical Investigation
(2.348)
Applied Microbiology And Biotechnology
(2.087)
Journal Of Diabetes Science And Technology
(1.934)
Bmj
(1.652)
British Journal Of Nutrition
(1.640)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Screening for Glucose Perturbations and Risk Factor Management in Dysglycemic Patients With Coronary Artery Disease-A Persistent Challenge in Need of Substantial Improvement: A Report From ESC EORP EUROASPIRE V

Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2

The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia

Development of SGLT1 and SGLT2 inhibitors

Editorial on “Quantification of Cerebral Glucose Concentrations via Detection of the H1‐α‐Glucose Peak in 1H MRS at 7T”

‘Smart’ insulin-delivery technologies and intrinsic glucose-responsive insulin analogues

The protein family of glucose transport facilitators: It's not only about glucose after all

What does sodium‐glucose co‐transporter 1 inhibition add: Prospects for dual inhibition

Loss of function of renal Glut2 reverses hyperglycaemia and normalises body weight in mouse models of diabetes and obesity

Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal Gestational Diabetes Mellitus and Childhood Glucose Metabolism

In Vitro and In Vivo Inhibition of Intestinal Glucose Transport by Guava (Psidium Guajava) Extracts

Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance : Results from the veterans administration genetic epidemiology study

Structural basis of inhibition of the human SGLT2–MAP17 glucose transporter

Do sodium‐glucose co‐transporter‐2 inhibitors increase plasma glucagon by direct actions on the alpha cell? And does the increase matter for the associated increase in endogenous glucose production?

Canagliflozin Lowers Postprandial Glucose and Insulin by Delaying Intestinal Glucose Absorption in Addition to Increasing Urinary Glucose Excretion: Results of a randomized, placebo-controlled study

Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart

No direct effect of SGLT2 activity on glucagon secretion

Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring

Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection

Dapagliflozin, a Selective SGLT2 Inhibitor, Improves Glucose Homeostasis in Normal and Diabetic Rats

Reduction in Global Myocardial Glucose Metabolism in Subjects With 1-Hour Postload Hyperglycemia and Impaired Glucose Tolerance

Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal Glycemia and Childhood Glucose Metabolism

Dapagliflozin improves insulin resistance and glucose intolerance in a novel transgenic rat model of chronic glucose overproduction and glucose toxicity

Understanding the clinical implications of differences between glucose management indicator and glycated haemoglobin

Sodium–glucose cotransporters: Functional properties and pharmaceutical potential

Aktive Filter

Suchergebnisse filtern